SCHEMBL7129459

SCHEMBL7129459

O=C(Nc1nc2ccc(Cc3ccc(F)cc3)cc2s1)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.55
ALDH1A1 P00352 5/20 0.55
LMNA P02545 4/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
KMT2A Q03164 6/20 0.54
MEN1 O00255 5/20 0.54
DYRK1A Q13627 1/20 0.53
MMP13 P45452 1/20 0.53
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
CACNA1B Q00975 1/20 0.53
APBA1 Q02410 1/20 0.53
MCL1 Q07820 1/20 0.52
RXFP1 Q9HBX9 1/20 0.52
HTT P42858 2/20 0.51
POLB P06746 1/20 0.51
MAPK1 P28482 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CXCR2 P25025 1/20 0.50
ALOX12 P18054 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7119606 0.90 MAPT (0.61) MAPTALDH1A1LMNASMN1; SMN2KMT2A
SCHEMBL7129461 0.86 DYRK1A (0.70) MAPTALDH1A1LMNASMN1; SMN2KMT2A
SCHEMBL7162058 0.84 DYRK1A (0.64) MAPTALDH1A1LMNASMN1; SMN2KMT2A
SCHEMBL7127487 0.83 MMP13 (0.74) MAPTALDH1A1LMNASMN1; SMN2KMT2A
SCHEMBL7124297 0.83 DYRK1A (0.61) MAPTALDH1A1LMNASMN1; SMN2KMT2A
SCHEMBL7125923 0.81 DYRK1A (0.57) MAPTALDH1A1LMNASMN1; SMN2KMT2A
SCHEMBL5731624 0.80 MAPT (0.69) MAPTALDH1A1LMNASMN1; SMN2KMT2A
SCHEMBL7123602 0.80 DYRK1A (0.67) MAPTALDH1A1LMNASMN1; SMN2KMT2A
SCHEMBL7127519 0.79 SCD (0.73) MAPTALDH1A1LMNASMN1; SMN2KMT2A
SCHEMBL26034899 0.78 NPC1 (0.77) MAPTALDH1A1LMNASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD MAPT 4391/4885ALDH1A1 583/4885LMNA 3310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.